Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer

99Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Abstract

The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.

Cite

CITATION STYLE

APA

Subramaniam, R. M., Truong, M., Peller, P., Sakai, O., & Mercier, G. (2010, April). Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.A1760

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free